Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, Regina Herbst, Friedrich Stoelzel, Christoph Röllig, Edgar Jost, Richard F. Schlenk, Richard Noppeney, Christian H. Brandts, Utz Krug, Katharina S. Goetze, Sebastian Buske, Axel Florschütz, Jörg Schubert, Bernhard Opitz, Martin Mohren, Eva Eßeling, Stephan von Witzendorff, Marion Subklewe, Martin Kaufmann, Norbert Frickhofen, Christian W Scholz, Kerstin Schäfer-Eckart, Volker Kunzmann, Martin Schmidt-Hieber, Herbert G. Sayer, Andreas Rank, Philipp Hemmati, Frank Schueler, Simone Kowoll, Marina Scheller, Jörg Steighardt, Bayram Edemir, Lutz Peter Mueller, Irit Gliko-Kabir, Beatrice Ludwig-Kraus, Sabine Edemir, Ella Sorani, Mascha Binder, Abi Vainstein, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhaeuser, Christian Junghanss, Carsten Mueller-Tidow

Blood (2022) 140 (Supplement 1): 3338–3340.

https://doi.org/10.1182/blood-2022-166748

Published: 2022

Journal Articles

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Frank Schueler, MD, Madelaine Hoffmann, Christian Pfrepper, Said Daneschnejad, Thoralf Lange, MD, Wolfram Pönisch, Haifa K. Al-Ali, Dietger W Niederwieser, MD, Nadezda Basara, MD

Blood (2010) 116 (21): 3544.

https://doi.org/10.1182/blood.V116.21.3544.3544

Published: 2010

Journal Articles

Reduction of Relapse Incidence and Improvement of Leukemia Free Survival by Allogeneic Stem Cell Transplantation in Patients with AML and Normal Karyotype Irrespective of the FLT3-ITD Status.

Frank Schueler, MD, Nadezda Basara, MD, Georg Maschmeyer, Thomas Fischer, Michael Herold, Herbert G. Sayer, MD, PhD, Hans-Heinrich Wolf, Ute Kreibich, Detlev Haehling, MD, Gottfried Doelken, MD, Christian Junghanss, MD, Norbert Grobe, Rainer Krahl, Haifa Kathrin Al-Ali, MD, Wolfram Poenisch, Dietger Niederwieser, MD

Blood (2009) 114 (22): 1612.

https://doi.org/10.1182/blood.V114.22.1612.1612

Published: 2009

Journal Articles

Assessment of Circulating t(14;18)-Positive Cells in 4152 Individuals without Lymphoma Shows Association with Age and Gender, but Not with Smoking Status: Results From the Population-Based Study of Health in Pomerania (SHIP).

Carsten Hirt, MD, Kerstin Weitmann, Frank Schueler, MD, Christian Späth, Wolfgang Hoffmann, MD, Gottfried Doelken, MD

Blood (2009) 114 (22): 3921.

https://doi.org/10.1182/blood.V114.22.3921.3921

Published: 2009

Journal Articles

Complete Molecular Remissions Due to Graft Versus Myeloma Effect after Allogeneic Blood Stem Cell Transplantation for Multiple Myeloma

Frank Schueler, MD, Carsten Hirt, MD, Thomas Kiefer, MD, Sandra Dölken, MD, William H. Krüger, MD, Gottfried Doelken, MD

Blood (2008) 112 (11): 4614.

https://doi.org/10.1182/blood.V112.11.4614.4614

Published: 2008

Journal Articles

Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.

Carsten Hirt, MD, Frank Schueler, MD, Thomas Kiefer, MD, Antje Haas, MD, Dietger Niederwieser, MD, Sabine Neser, MD, Michael Assmann, MD, Klaus Dachselt, MD, Malte Leithaeuser, MD, Charles S. Rabkin, MD, Michael Herold, MD, Gottfried Dolken, MD

Blood (2006) 108 (11): 2757.

https://doi.org/10.1182/blood.V108.11.2757.2757

Published: 2006

Journal Articles

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Cristina Bertinetti, PhD, Frank Schueler, MD, Kristina Heining-Mikesch, MD, Katja Zirlik, MD, Tina Tomann, MD, Brigitte Franke, MD, Gottfried Dolken, MD, Hendrik Veelken, MD

Blood (2006) 108 (11): 2726.

https://doi.org/10.1182/blood.V108.11.2726.2726

Published: 2006

NARROW

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Reduction of Relapse Incidence and Improvement of Leukemia Free Survival by Allogeneic Stem Cell Transplantation in Patients with AML and Normal Karyotype Irrespective of the FLT3-ITD Status.

Assessment of Circulating t(14;18)-Positive Cells in 4152 Individuals without Lymphoma Shows Association with Age and Gender, but Not with Smoking Status: Results From the Population-Based Study of Health in Pomerania (SHIP).

Complete Molecular Remissions Due to Graft Versus Myeloma Effect after Allogeneic Blood Stem Cell Transplantation for Multiple Myeloma

Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Email alerts

ASH Publications

American Society of Hematology

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Reduction of Relapse Incidence and Improvement of Leukemia Free Survival by Allogeneic Stem Cell Transplantation in Patients with AML and Normal Karyotype Irrespective of the FLT3-ITD Status.

Assessment of Circulating t(14;18)-Positive Cells in 4152 Individuals without Lymphoma Shows Association with Age and Gender, but Not with Smoking Status: Results From the Population-Based Study of Health in Pomerania (SHIP).

Complete Molecular Remissions Due to Graft Versus Myeloma Effect after Allogeneic Blood Stem Cell Transplantation for Multiple Myeloma

Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.

Kinetics of Immune Responses and Tumor Burden in Patients with Indolent B Cell Lymphomas Receiving Recombinant Idiotype Vaccination as the Sole Treatment.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only